# OPIPZA
> **NDA216655** · New Drug Application · Sponsor: XIAMEN LP PHARM CO · Approved 2024-07-22
## Drug
- **FDA Application Number:** NDA216655
- **Application type:** New Drug Application
- **Brand name:** OPIPZA
- **Generic name:** ARIPIPRAZOLE
- **Active ingredients:** ARIPIPRAZOLE
- **Dosage form:** FILM
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** XIAMEN LP PHARM CO
- **Manufacturer:** Carwin Pharmaceutical Associates, LLC
- **First approval:** 2024-07-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216655)
---
*AI Analytics · CC0 1.0*